The label promises 5,000 mg per serving. The panel says 5,000 mg. They match.

Creatine for Women
Checked against public sources on July 20, 2026 · LookCloser does not sell or recommend supplements.
Does the marketing hold up?
1 ingredient’ amounts are hidden inside “BCAA Blend”. The label gives one combined figure of 500mg for Vitamin B12 (as Methylcobalamin), and no amount for any of them individually. You cannot tell whether any one reaches a dose used in research — it could be…
“Couldn’t verify” means we looked and found no public proof — not a mark against the product. Most supplement claims cannot be independently verified by anyone, so grey is the normal state of this industry.
What the Supplement Facts panel says
| Calories | 12 |
|---|---|
| Total Carbohydrates | 4g |
| Sugars | 0g |
| Creatine Monohydrate | 5000mg |
| Collagen | 1000mg |
| BCAA Blend | 500mg |
| Vitamin B12 (as Methylcobalamin) | 50mcg |
We read 7 lines from the package photograph. It is our transcript of the label, not the manufacturer’s panel, and it may be incomplete.
The checks, one by one
1 promise checks out. 1 could not be fully confirmed from public sources.
✓Matches the label1
◐Partly confirmed1
Ingredient evidence exists; on dose: label claims 5000 mg/serving — within the range commonly used in research (3–5 g/day maintenance across trials (short loading phases use more)).
Ingredient research can support context, but it is not a trial of this exact product.
What is worth knowing.
Headlines first. Open evidence only when you want the source trail.
Creatine in a gummy can degrade in moist, acidic conditions.
Moist, acidic formats can reduce the active ingredient over time, so the delivered amount may be lower than the label says.
Evidence and sources
Creatine is stable as dry powder, while published stability research shows faster degradation as moisture and temperature rise. A gummy's delivered amount therefore depends on formulation and shelf-life testing; this record does not test this product.
Reviews rose from 35 to 58 between July 17 and August 28, 2026 — no sudden jump.
A count that moves steadily is ordinary. A sudden burst is what deserves a closer look.
Evidence and sources
Written reviews rose from 35 to 58 between July 17 and August 28, 2026. The largest rise inside any single 30-day window was about 22, so the count moved in steps rather than in one burst.
Locked evidence record →Open the full source-linked findingWhat remains open 2
- No FDA recall matched this brand in the current search.
- Brand ownership is not settled in this record.
These are evidence gaps, not strikes against the product.
Dose and research context
We could not match an amount on this product to a studied range for the same ingredient, so these links are ingredient background rather than a measurement of this product.
Where you can check or buy it
Only the submitted seller page is identity-certain. Other destinations are shown as leads until a shared UPC/GTIN confirms the exact product.
Amazon
Submitted listingLowest New observed via Keepa on 2026-09-01.
View on Amazon ↗iHerb
Not confirmedNo matching product page was confirmed in the current record. Search results cannot be attached as this product until the UPC/GTIN matches.
Search iHerb ↗Target
Not confirmedNo matching product page was confirmed in the current record. Search results cannot be attached as this product until the UPC/GTIN matches.
Search Target ↗Walmart
Not confirmedNo matching product page was confirmed in the current record. Search results cannot be attached as this product until the UPC/GTIN matches.
Search Walmart ↗Prices and stock are point-in-time observations. Related pages are never used as product evidence. No affiliate links; LookCloser earns nothing from these sellers.
Want to inspect the evidence?
The full report shows every source, the exact unresolved question, and the documentation that would settle it.
Record built September 03, 2026. Sources: source listing observed at check time · USPTO Trademark Search · Keepa exact-listing history · NIH / published research · certification and regulator records where available. LookCloser publishes evidence and gaps; it does not advise for or against any supplement. Evidence-based corrections welcome.